WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience Introducing ALZET?ew Model 2006 Pump
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Piggins, H. D.
Right arrow Articles by Rusak, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Piggins, H. D.
Right arrow Articles by Rusak, B.

 Previous Article  |  Next Article 

Journal of Neuroscience, Vol 15, 5612-5622, Copyright © 1995 by Society for Neuroscience


ARTICLE

Neuropeptides phase shift the mammalian circadian pacemaker

HD Piggins, MC Antle and B Rusak
Department of Psychology, Dalhousie University, Halifax, Nova Scotia, Canada.

We studied the influence on circadian rhythms of peptides that have been reported to be colocalized in suprachiasmatic nucleus (SCN) neurons. Gastrin-releasing peptide (GRP1-27), peptide histidine isoleucine (PHI), and vasoactive intestinal polypeptide (VIP) were microinjected into the suprachiasmatic nucleus (SCN) region of Syrian hamsters free running under three different constant lighting conditions. All peptide injections caused phase-dependent phase shifts of hamster locomotor activity rhythms which were unaffected by constant lighting conditions. GRP1-27 (150 pmol) caused large phase delays when injected at circadian times (CT) 12-16, modest phase advances when administered at CT20-24, and few shifts during the subjective day. Injections of saline vehicle at any of these phases caused only very small phase shifts. Phase delays induced by GRP1-27 at CT12-14 were dose dependent, unrelated to injection volume (at a constant dose), and attenuated by pretreatment with the BN/GRP-preferring receptor antagonist BIM 26226. VIP (150 pmol) caused moderate phase delays at CT12-14 and moderate phase advances at CT20-24. PHI (150 pmol) caused moderate phase delays at CT12-14 only. Coadministration of 150 pmol of GRP1-27, PHI, and VIP in an equimolar neuropeptide cocktail (50 pmol of each peptide) caused phase delays at CT12-14 and phase advances at CT20- 24 which did not differ from those induced by 150 pmol of GRP1-27 alone at these phases. The shifts induced by 150 pmol of the peptide cocktail were smaller than the sum of the shifts induced by 50 pmol doses of each peptide administered separately at those phases. Since the phase- delaying effects of the cocktail were weaker than the summed effects of the component 50 pmol doses of the peptides, these data demonstrate a lack of synergism among the effects of these peptides. Since GRP1-27 (150 pmol) evoked shifts similar in magnitude to those of the cocktail, there is no evidence that these apparently colocalized neuropeptides must interact to exert maximal effects on the circadian pacemaker.


This article has been cited by other articles:


Home page
Biophys. JHome page
S. R. Taylor, F. J. Doyle 3rd, and L. R. Petzold
Oscillator Model Reduction Preserving the Phase Response: Application to the Circadian Clock
Biophys. J., August 15, 2008; 95(4): 1658 - 1673.
[Abstract] [Full Text] [PDF]


Home page
J Biol RhythmsHome page
A.T.L. Hughes and H.D. Piggins
Behavioral Responses of Vipr2-/- Mice to Light
J Biol Rhythms, June 1, 2008; 23(3): 211 - 219.
[Abstract] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. A. Bechtold, T. M. Brown, S. M. Luckman, and H. D. Piggins
Metabolic rhythm abnormalities in mice lacking VIP-VPAC2 signaling
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2008; 294(2): R344 - R351.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. L. Gamble, G. C. Allen, T. Zhou, and D. G. McMahon
Gastrin-Releasing Peptide Mediates Light-Like Resetting of the Suprachiasmatic Nucleus Circadian Pacemaker through cAMP Response Element-Binding Protein and Per1 Activation
J. Neurosci., October 31, 2007; 27(44): 12078 - 12087.
[Abstract] [Full Text] [PDF]


Home page
J Biol RhythmsHome page
P. Indic, W. J. Schwartz, E. D. Herzog, N. C. Foley, and M. C. Antle
Modeling the Behavior of Coupled Cellular Circadian Oscillators in the Suprachiasmatic Nucleus
J Biol Rhythms, June 1, 2007; 22(3): 211 - 219.
[Abstract] [PDF]


Home page
Biophys. JHome page
T.-L. To, M. A. Henson, E. D. Herzog, and F. J. Doyle III
A Molecular Model for Intercellular Synchronization in the Mammalian Circadian Clock
Biophys. J., June 1, 2007; 92(11): 3792 - 3803.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
H. Hao, D. E. Zak, T. Sauter, J. Schwaber, and B. A. Ogunnaike
Modeling the VPAC2-Activated cAMP/PKA Signaling Pathway: From Receptor to Circadian Clock Gene Induction
Biophys. J., March 1, 2006; 90(5): 1560 - 1571.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. M. Brown, A. T. Hughes, and H. D. Piggins
Gastrin-Releasing Peptide Promotes Suprachiasmatic Nuclei Cellular Rhythmicity in the Absence of Vasoactive Intestinal Polypeptide-VPAC2 Receptor Signaling
J. Neurosci., November 30, 2005; 25(48): 11155 - 11164.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. C. Antle, L. J. Kriegsfeld, and R. Silver
Signaling within the Master Clock of the Brain: Localized Activation of Mitogen-Activated Protein Kinase by Gastrin-Releasing Peptide
J. Neurosci., March 9, 2005; 25(10): 2447 - 2454.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. T. Hughes, B. Fahey, D. J. Cutler, A. N. Coogan, and H. D. Piggins
Aberrant Gating of Photic Input to the Suprachiasmatic Circadian Pacemaker of Mice Lacking the VPAC2 Receptor
J. Neurosci., April 7, 2004; 24(14): 3522 - 3526.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
I. N. Karatsoreos, L. Yan, J. LeSauter, and R. Silver
Phenotype Matters: Identification of Light-Responsive Cells in the Mouse Suprachiasmatic Nucleus
J. Neurosci., January 7, 2004; 24(1): 68 - 75.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. S. Colwell, S. Michel, J. Itri, W. Rodriguez, J. Tam, V. Lelievre, Z. Hu, X. Liu, and J. A. Waschek
Disrupted circadian rhythms in VIP- and PHI-deficient mice
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2003; 285(5): R939 - R949.
[Abstract] [Full Text] [PDF]


Home page
J Biol RhythmsHome page
J. H. Meijer and W. J. Schwartz
In Search of the Pathways for Light-Induced Pacemaker Resetting in the Suprachiasmatic Nucleus
J Biol Rhythms, June 1, 2003; 18(3): 235 - 249.
[Abstract] [PDF]


Home page
Pharmacol. Rev.Home page
V. Simonneaux and C. Ribelayga
Generation of the Melatonin Endocrine Message in Mammals: A Review of the Complex Regulation of Melatonin Synthesis by Norepinephrine, Peptides, and Other Pineal Transmitters
Pharmacol. Rev., June 1, 2003; 55(2): 325 - 395.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. J. Kuhlman, R. Silver, J. Le Sauter, A. Bult-Ito, and D. G. McMahon
Phase Resetting Light Pulses Induce Per1 and Persistent Spike Activity in a Subpopulation of Biological Clock Neurons
J. Neurosci., February 15, 2003; 23(4): 1441 - 1450.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. Aida, T. Moriya, M. Araki, M. Akiyama, K. Wada, E. Wada, and S. Shibata
Gastrin-Releasing Peptide Mediates Photic Entrainable Signals to Dorsal Subsets of Suprachiasmatic Nucleus via Induction of Period Gene in Mice
Mol. Pharmacol., January 1, 2002; 61(1): 26 - 34.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. Hamada, J. LeSauter, J. M. Venuti, and R. Silver
Expression of Period Genes: Rhythmic and Nonrhythmic Compartments of the Suprachiasmatic Nucleus Pacemaker
J. Neurosci., October 1, 2001; 21(19): 7742 - 7750.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Shen, C. Spratt, W. J. Sheward, I. Kallo, K. West, C. F. Morrison, C. W. Coen, H. M. Marston, and A. J. Harmar
Overexpression of the human VPAC2 receptor in the suprachiasmatic nucleus alters the circadian phenotype of mice
PNAS, October 10, 2000; 97(21): 11575 - 11580.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. J. McArthur, A. N. Coogan, S. Ajpru, D. Sugden, S. M. Biello, and H. D. Piggins
Gastrin-Releasing Peptide Phase-Shifts Suprachiasmatic Nuclei Neuronal Rhythms In Vitro
J. Neurosci., July 15, 2000; 20(14): 5496 - 5502.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Obrietan, S. Impey, D. Smith, J. Athos, and D. R. Storm
Circadian Regulation of cAMP Response Element-mediated Gene Expression in the Suprachiasmatic Nuclei
J. Biol. Chem., June 18, 1999; 274(25): 17748 - 17756.
[Abstract] [Full Text] [PDF]


Home page
J Biol RhythmsHome page
C. F. Gillespie, K. L. Huhman, T. O. Babagbemi, and H. E. Albers
Bicuculline Increases and Muscimol Reduces the Phase-Delaying Effects of Light and VIP/PHI/GRP in the Suprachiasmatic Region
J Biol Rhythms, June 1, 1996; 11(2): 137 - 144.
[Abstract] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-